Article Details

Allogene moved to Not Rated on strategy shift at Goldman Sachs - TipRanks.com

Retrieved on: 2024-01-05 19:20:04

Tags for this article:

Click the tags to see associated articles and topics

Allogene moved to Not Rated on strategy shift at Goldman Sachs - TipRanks.com. View article details on hiswai:

Excerpt

Goldman Sachs analyst Salveen Richter moved shares of Allogene Therapeutics to Not Rated after the company announced a strategy shift across its ...

Article found on: www.tipranks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo